BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38878852)

  • 1. Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing.
    Feng HR; Shen XN; Zhu XM; Zhong WT; Zhu DX; Zhao J; Chen YJ; Shen F; Liu K; Liang L
    Cancer Lett; 2024 Jun; 597():217062. PubMed ID: 38878852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.
    Zhang Z; Wang ZX; Chen YX; Wu HX; Yin L; Zhao Q; Luo HY; Zeng ZL; Qiu MZ; Xu RH
    Genome Med; 2022 Apr; 14(1):45. PubMed ID: 35488273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy.
    Liu C; Xie J; Lin B; Tian W; Wu Y; Xin S; Hong L; Li X; Liu L; Jin Y; Tang H; Deng X; Zou Y; Zheng S; Fang W; Cheng J; Dai X; Bao X; Zhao P
    Adv Sci (Weinh); 2024 Jun; 11(23):e2401061. PubMed ID: 38569519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication.
    Chen D; Liu P; Lu X; Li J; Qi D; Zang L; Lin J; Liu Y; Zhai S; Fu D; Weng Y; Li H; Shen B
    J Exp Clin Cancer Res; 2024 Apr; 43(1):125. PubMed ID: 38664705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive pan-cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance.
    Chen Q; Gao F; Wu J; Zhang K; Du T; Chen Y; Cai R; Zhao D; Deng R; Tang J
    Clin Transl Med; 2024 Jun; 14(6):e1735. PubMed ID: 38899748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response.
    Zhang W; Zhu Y; Liu H; Zhang Y; Liu H; Adegboro AA; Dang R; Dai L; Wanggou S; Li X
    NPJ Precis Oncol; 2024 Mar; 8(1):77. PubMed ID: 38538696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
    Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Infiltrating PD-1
    Yang Z; Deng Y; Cheng J; Wei S; Luo H; Liu L
    Front Oncol; 2021; 11():695006. PubMed ID: 34604032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell transcriptomic-informed deconvolution of bulk data identifies immune checkpoint blockade resistance in urothelial cancer.
    Wang L; Izadmehr S; Sfakianos JP; Tran M; Beaumont KG; Brody R; Cordon-Cardo C; Horowitz A; Sebra R; Oh WK; Bhardwaj N; Galsky MD; Zhu J
    iScience; 2024 Jun; 27(6):109928. PubMed ID: 38812546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
    Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
    Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence.
    Wu Z; Uhl B; Gires O; Reichel CA
    J Biomed Sci; 2023 Mar; 30(1):21. PubMed ID: 36978029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Zhang Z; Tan J; Yu Z; Liu C; Wang J; Wu D; Bai X
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):667-679. PubMed ID: 37313807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy.
    Feng JL; Liang B; Zheng WJ; Xu L; Zhou QY; Chen J
    Cancer Immunol Immunother; 2024 May; 73(7):121. PubMed ID: 38714579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
    Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-Cancer Analysis Reveals Disulfidoptosis-Associated Genes as Promising Immunotherapeutic Targets: Insights Gained from Bulk Omics and Single-Cell Sequencing Validation.
    Xu B; Li M; Weng N; Zhou C; Chen Y; Wei J; Fu L
    Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
    Chai R; Zhao Y; Su Z; Liang W
    Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
    Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
    Front Genet; 2022; 13():833797. PubMed ID: 35154287
    [No Abstract]   [Full Text] [Related]  

  • 20. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
    Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
    Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.